Position in MRK
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,508,529,698
+$162,432,091 QoQ
Shares Held
12,540,774
-1.9% QoQ
Ownership
0.508%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 30.709165159981357.ToString("F0")%
Shared 0.ToString("F0")%
None 69.29083484001865.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Jun 30, 2020CallValue
$5,534
CallShares
75
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $16,087,469,920 across 16 Drug Manufacturers - General names. MRK ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,435,647 | $3,528,649,542 | |
| 2 | LLY |
ELI LILLY & Co
|
3,547,772 | $3,263,134,246 | |
| 3 | AZN |
Astrazeneca PLC
|
12,129,724 | $2,392,224,162 | |
| 4 | ABBV |
AbbVie Inc.
|
9,531,362 | $2,072,975,912 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
12,540,774 | $1,508,529,698 | |
| 6 | PFE |
Pfizer Inc
|
31,428,987 | $882,525,946 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,222,328 | $867,205,844 | |
| 8 | AMGN |
Amgen Inc
|
2,255,759 | $793,688,795 |
All Filings in MRK
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,508,529,698 | 12,540,774 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $1,346,097,607 | 12,788,311 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,413,915,071 | 16,846,361 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,349,093,950 | 17,042,622 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,720,918,745 | 19,172,446 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,914,637,534 | 19,246,457 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $2,222,234,283 | 19,568,812 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $2,575,548,318 | 20,804,106 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $2,803,025,324 | 21,243,087 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $2,351,972,614 | 21,573,772 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,989,405,998 | 19,324,002 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $2,483,421,032 | 21,521,978 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,413,435,648 | 22,684,798 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,307,124,468 | 20,794,272 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,843,738,936 | 21,408,952 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,985,909,147 | 21,782,485 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,898,324,954 | 23,136,197 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,655,180,272 | 21,596,820 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,639,351,374 | 21,826,007 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,684,254,538 | 21,656,867 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,561,409,868 | 21,226,575 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,566,362,427 | 20,067,831 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,594,144,196 | 20,140,595 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,534 | 75 | Call | Defined | 2020-08-13 | |
| 2020-06-30 | $1,694,801,379 | 22,968,461 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $26,209 | 357 | Call | Defined | 2020-05-14 | |
| 2020-03-31 | $47,279 | 644 | Put | Defined | 2020-05-14 | |
| 2020-03-31 | $1,680,713,431 | 22,893,013 | Shares | Other | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||